Billy Evans, partner of Theranos founder Elizabeth Holmes, is launching a new blood-testing venture called Haemanthus, raising eyebrows and questions about repeating past mistakes in health technology.
Discover the crucial insights from Fortune Media that could change your financial game. Don't miss the essential tips and updates that Fortune provides!
Good Monday morning! NYC is buzzing with news as safety metrics soar thanks to congestion pricing, while legal weed shops face vape sales halts and Andrew Yang stumbles in comedy. Plus, Bob Menendez's prison date delay and Elizabeth Holmes' husband seeks funds for a new venture!
Billy Evans, partner of Theranos founder Elizabeth Holmes, is raising millions for Haemanthus, a new blood-testing company with striking similarities to its infamous predecessor. Can he succeed where Holmes failed?
Billy Evans, partner of Theranos founder Elizabeth Holmes, unveils Haemanthus, a startup aiming to revolutionize health optimization through advanced blood testing. With ambitions to raise over $50 million, this venture echoes Theranos' controversial legacy. Is it a groundbreaking innovation or a repeat of past mistakes?
In a surprising turn of events, Elizabeth Holmes' partner, Billy Evans, raises millions for an AI startup named Haemanthus, aimed at revolutionizing medical testing. As Holmes advises from prison, the venture seeks to make advanced diagnostic tools accessible to patients.
Elizabeth Holmes, founder of Theranos, remains in prison as court upholds fraud conviction for deceiving investors with false claims about her blood-testing startup. Learn about the scandal and the legal battle.
US court upholds convictions of Theranos' founder Elizabeth Holmes and President Ramesh “Sunny” Balwani for defrauding investors in the failed blood testing startup once valued at $9 billion.
